Novozymes and Bactolife join forces to significantly reduce post weaning diarrhea and antibiotic use among weaner pigs
September 04, 2023 03:07 ET
|
Novozymes A/S
The two companies have signed a joint development and commercialization agreement to launch feed additive Ablacto+. The game changing biosolution uses binding proteins to stabilize the gut of...
Trading by management and close relations of management
August 25, 2023 08:36 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2023_56_Trading_by_management
...
Trading by management and close relations of management
August 15, 2023 09:55 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2023_55_Trading_by_management
...
Novozymes delivers results within expectations in the first half of 2023 and narrows the full year outlook
August 09, 2023 01:59 ET
|
Novozymes A/S
After the first half of 2023, Novozymes sees overall stability in a volatile environment and delivers 3% organic sales growth. Following destocking and lower consumer demand, the organic full-year...
Interim report for 1H 2023
August 09, 2023 01:58 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2023_54_Q22023_CompanyAnnouncement
...
Change to the Executive Leadership Team
May 04, 2023 06:01 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2023_53_Change_to_the_Executive_Leadership_Team
...
Novozymes delivers stronger than expected Q1 results
April 26, 2023 01:59 ET
|
Novozymes A/S
After the first quarter of 2023, Novozymes delivers stronger results than expected with 5% organic sales growth. The company confirms the 2023 outlook of 4-7% which is expected to be driven by pricing...
Interim report for Q1 2023
April 26, 2023 01:58 ET
|
Novozymes A/S
Please read the full report in PDF
Attachment
2023_52_Q12023_CompanyAnnouncement
...
Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
March 30, 2023 12:00 ET
|
Novozymes A/S
The proposed combination of Novozymes and Chr. Hansen has now been approved by each company’s respective shareholders, and with strong support from the shareholders the two biosolutions companies...
Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner
March 30, 2023 11:59 ET
|
Novozymes A/S
Please read the announcement in PDF
Attachment
2023_Novozymes’_and_Chr._Hansen’s_shareholders_approve_combination
...